Late-Breaking Abstract 1: Randomized phase III noninferiority trial of first line chemotherapy for metastatic or recurrent endometrial carcinoma: A Gynecologic Oncology Group study

Oncology Group ◽

First Line ◽

Oncology Group Study ◽

Noninferiority Trial ◽

Phase II trial of clsplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: A gynecologic oncology group study

Gynecologic Oncology ◽

10.1016/0090-8258(89)90605-7 ◽

1989 ◽

Vol 33 (1) ◽

pp. 68-70 ◽

Cited By ~ 116

Author(s):

J.Tate Thigpen ◽

John A. Blessing ◽

Howard Homesley ◽

William T. Creasman ◽

Gregory Sutton

Keyword(s):

Endometrial Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Gynecologic Oncology ◽

Oncology Group ◽

First Line ◽

Oncology Group Study ◽

Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study

International Journal of Gynecology & Obstetrics ◽

10.1016/0020-7292(89)90346-9 ◽

1989 ◽

Vol 30 (2) ◽

pp. 196-196

Author(s):

Jt Thigpen ◽

JA Blessing ◽

H Homesley ◽

WT Creasman ◽

G Sutton

Keyword(s):

Endometrial Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Gynecologic Oncology ◽

Oncology Group ◽

First Line ◽

Oncology Group Study ◽

Phase II study of oxaliplatin as second-line chemotherapy in endometrial carcinoma: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2006.03.043 ◽

2006 ◽

Vol 103 (2) ◽

pp. 523-526 ◽

Cited By ~ 30

Author(s):

Paula M. Fracasso ◽

John A. Blessing ◽

Kelly L. Molpus ◽

Lisa M. Adler ◽

Joel I. Sorosky ◽

...

Keyword(s):

Endometrial Carcinoma ◽

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Second Line ◽

Oncology Group ◽

Oncology Group Study ◽

Second Line Chemotherapy ◽

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study

The Women s Oncology Review ◽

10.3109/14733400412331312594 ◽

2004 ◽

Vol 4 (3) ◽

pp. 205-207

Keyword(s):

Endometrial Carcinoma ◽

Gynecologic Oncology ◽

Phase Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2008.11.014 ◽

2009 ◽

Vol 112 (3) ◽

pp. 543-552 ◽

Cited By ~ 139

Author(s):

Howard D. Homesley ◽

Virginia Filiaci ◽

Susan K. Gibbons ◽

Harry J. Long ◽

David Cella ◽

...

Keyword(s):

Endometrial Carcinoma ◽

Gynecologic Oncology ◽

Phase Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

Phase III Trial of Doxorubicin With or Without Cisplatin in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

Yearbook of Obstetrics Gynecology and Women s Health ◽

10.1016/s1090-798x(08)70601-5 ◽

2006 ◽

Vol 2006 ◽

pp. 457-458

Author(s):

D.S. Miller

Keyword(s):

Endometrial Carcinoma ◽

Gynecologic Oncology ◽

Phase Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

Faculty Opinions recommendation of A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1158196.617794 ◽

2009 ◽

Author(s):

Enrico Sartori

Keyword(s):

Endometrial Carcinoma ◽

Gynecologic Oncology ◽

Phase Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

Randomized phase III trial of paclitaxel/carboplatin (PC) versus cisplatin/irinotecan (CPT-P) as first-line chemotherapy in patients with clear cell carcinoma (CCC) of the ovary: A Japanese Gynecologic Oncology Group (JGOG)/GCIG study.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.5507 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 5507-5507 ◽

Cited By ~ 9

Author(s):

Aikou Okamoto ◽

Toru Sugiyama ◽

Tetsutaro Hamano ◽

Jae Weon Kim ◽

Byoung Gie Kim ◽

...

Keyword(s):

Cell Carcinoma ◽

Clear Cell ◽

Clear Cell Carcinoma ◽

Gynecologic Oncology ◽

Phase Iii ◽

Oncology Group ◽

First Line ◽

Phase Iii Trial ◽

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a gynecologic oncology group study

The Women s Oncology Review ◽

10.1080/14733400500034431 ◽

2004 ◽

Vol 4 (4) ◽

pp. 287-289

Keyword(s):

Endometrial Carcinoma ◽

Gynecologic Oncology ◽

Phase Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

Phase III randomized trial of doxorubicin + cisplatin versus doxorubicin + 24-h paclitaxel + filgrastim in endometrial carcinoma: a Gynecologic Oncology Group study

Annals of Oncology ◽

10.1093/annonc/mdh316 ◽

2004 ◽

Vol 15 (8) ◽

pp. 1173-1178 ◽

Cited By ~ 161

Author(s):

G.F. Fleming ◽

V.L. Filiaci ◽

R.C. Bentley ◽

T. Herzog ◽

J. Sorosky ◽

...

Keyword(s):

Randomized Trial ◽

Endometrial Carcinoma ◽

Gynecologic Oncology ◽

Phase Iii ◽

Oncology Group ◽